• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
Sunday, February 5, 2023
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • CONTACT US
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

The SARS-CoV-2 RBD antigen could be produced by bio-engineered plants for large-scale use in serology tests and vaccines

Bioengineer by Bioengineer
December 14, 2022
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Article URL:  https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0277668

The SARS-CoV-2 RBD antigen could be produced by bio-engineered plants for large-scale use in serology tests and vaccines

Credit: Allyson MacLean, CC-BY 4.0 (https://creativecommons.org/licenses/by/4.0/)

Article URL:  https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0277668

Article Title: Scalable agroinfiltration-based production of SARS-CoV-2 antigens for use in diagnostic assays and subunit vaccines

Author Countries: Canada

Funding: This study was funded in part by a COVID-19 Rapid Response grant by the Canadian Institute of Health Research (CIHR, #VR2 – 172722) and by a grant supplement by the Canadian Immunity Task Force (CITF) to MAL. MM holds a Queen Elizabeth II Graduate Scholarship in Science and Technology (QEII-GSST) and YG holds a Canadian Institute of Health Research (CIHR) Frederick Banting and Charles Best graduate scholarship (CGS-M). Production of RBD was supported financially by the National Research Council Canada Pandemic Response Challenge program. Greenhouse management was supported by funding from the University of Ottawa Faculty of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.



Journal

PLoS ONE

DOI

10.1371/journal.pone.0277668

Article Title

Scalable agroinfiltration-based production of SARS-CoV-2 antigens for use in diagnostic assays and subunit vaccines

Article Publication Date

14-Dec-2022

COI Statement

The authors have declared that no competing interests exist.

Share12Tweet8Share2ShareShareShare2

Related Posts

road

Black South Africans report higher life satisfaction and are at less risk for depression post-migration, MU study finds

February 3, 2023
Lifetime Uncertainty and Level of Violence Global Map

Living in a violent setting can result in a shorter, but also a more unpredictable lifespan, according to new research from NYU Abu Dhabi social scientists

February 3, 2023

Harnessing an innate protection against Ebola

February 3, 2023

Signal transmission in the immune and nervous system through NEMO

February 3, 2023

POPULAR NEWS

  • Jean du Terrail, Senior Machine Learning Scientist at Owkin

    Nature Medicine publishes breakthrough Owkin research on the first ever use of federated learning to train deep learning models on multiple hospitals’ histopathology data

    65 shares
    Share 26 Tweet 16
  • First made-in-Singapore antibody-drug conjugate (ADC) approved to enter clinical trials

    58 shares
    Share 23 Tweet 15
  • Metal-free batteries raise hope for more sustainable and economical grids

    41 shares
    Share 16 Tweet 10
  • One-pot reaction creates versatile building block for bioactive molecules

    37 shares
    Share 15 Tweet 9

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Health Equity Report Card pilot project to help close the care gap highlighted on World Cancer Day

Tech that turns household surfaces into touch sensors is a touch closer to application

Preference for naturally talented over hard workers emerges in childhood, HKUST researchers find

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 42 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In